Document 0017
 DOCN  M9550017
 TI    HIV seropositivity in Nigerians with lymphoproliferative malignancies.
 DT    9505
 AU    Okpala IE; Shokunbi WA; Saliu I; Akinboye DO; Essien EM; Department of
       Haematology, University College Hospital, Ibadan,; Nigeria.
 SO    Afr J Med Med Sci. 1993 Dec;22(4):73-6. Unique Identifier : AIDSLINE
       MED/95141906
 AB    One hundred and four Nigerians with lymphoproliferative malignancies
       were tested for antibodies to human immunodeficiency virus types 1 and 2
       (HIV-1 and 2). All the patients with high grade lymphomas in this series
       were seronegative for HIV-1 and 2. Only 1 of the 104 patients had
       antibody to HIV-1 and none had antibody to HIV-2. Although the single
       positive result would suggest a higher HIV-1 seropositivity rate among
       the patients compared with the general Nigerian population, it should be
       interpreted with caution. This preliminary data emphasizes the need for
       an urgent countrywide study of the problem among this category of
       patients in Nigeria in view of the low prevalence rate of HIV-1 and 2 in
       the country.
 DE    Adolescence  Adult  Aged  Child  Child, Preschool  Female  Health
       Services Needs and Demand  Human  HIV
       Seropositivity/BLOOD/COMPLICATIONS/*EPIDEMIOLOGY  *HIV Seroprevalence
       *HIV-1  *HIV-2  Incidence  Infant  Lymphoproliferative
       Disorders/*COMPLICATIONS/EPIDEMIOLOGY  Male  Middle Age
       Nigeria/EPIDEMIOLOGY  *Population Surveillance  Seroepidemiologic
       Methods  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).